Turin, Italy welcomes the 2014 edition of BIO-Europe Spring®

The eighth annual BIO-Europe Spring® conference will be held March 10–12, 2014 in Turin, Italy at the OVAL Lingotto conference center. The event is recognized by life science insiders as the place for established biotech and early-stage companies to meet and form partnerships with venture capitalists and business development executives from big pharma companies.

Investor and pharma partners provide life science companies with benefits that go beyond financial investment to include business experience and advice on issues ranging from regulatory and approval benchmarks to marketing and patient advocacy that enable them to transform their early stage discovery into marketable therapies and cures.

“We are very excited to bring BIO-Europe Spring to Turin in 2014,” said Florian Schoenhammer, Group Managing Director, EBD Group. “The Piemonte region has a thriving life science community that benefits from a well-supported infrastructure for research and drug discovery. And Italy has applied the same passion and innovation to their biotech sector that has historically made them a leader in the automotive, financial, culinary and fashion industries.”

The Turin and Piemonte region is an ideal location for BIO-Europe Spring as it is the location of 360 life science companies with 7,000 employees. It is also home to four universities, four incubators, six science and technology parks, 220 R&D centers, and 380 labs comprising 23,300 researchers.

“I would personally like to thank EBD Group for bringing BIO-Europe Spring 2014 to our city, giving Torino high media visibility. During BIO-Europe Spring in Barcelona in March, and BIO-Europe in Vienna in November, we had many visitors to our booth who showed interest in our region, including foreign companies, research centers and entrepreneurial associations from countries with whom we have not previously been in contact,” said Alessandro Barberis, President of the Torino Chamber of Commerce.

BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship life science partnering conference, BIO-Europe®. Companies participate in one-to-one partnering meeting facilitated by EBD Group’s highly reputable partneringONE platform.

In 2013, BIO-Europe Spring was held in Barcelona, Spain, where over 2,000 attendees from 1,219 companies participated in 10,805 one-to-one meetings involving 2,148 licensing opportunities. BIO-Europe Spring will continue to provide life science companies with high caliber partnering opportunities in Turin, Italy.

Register before January 17 and save EUR 200 off the regular registration fee

partneringONE® is EBD Group’s sophisticated, web-based partnering system that enables event delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit

About BIO-Europe Spring® 2014

As the springtime counterpart to BIO-Europe®, BIO-Europe Spring® continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s acclaimed partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the biotech value chain.

In addition to productive partnering, BIO-Europe Spring offers high level workshops, panels, company presentations, and a lively exhibition. The program features executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative start-ups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy.

Combined, these elements create an insightful and productive event that will have you coming back year after year.

BIO-Europe Spring is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Industry Organization (BIO).

Follow BIO-Europe Spring 2014 on Twitter: (hashtag: #BES14). Or log on to the BIO-Europe Spring 2014 Discussion Forum on partnering360. The Group is your go-to discussion forum for news and topics related to BIO-Europe Spring.